Literature DB >> 24369219

Interdigitating dendritic cell sarcoma and follicular dendritic cell sarcoma: histopathological findings for differential diagnosis.

Hiroya Ohtake1, Mitsunori Yamakawa.   

Abstract

Both interdigitating cell sarcoma (IDCS) and follicular dendritic cell sarcoma (FDCS) are rare neoplasms derived from dendritic cells in lymphoid organs. IDCS is defined as a neoplastic proliferation of spindle-shaped to ovoid cells with phenotypic features similar to those of IDCs. FDCS is a malignant neoplasm derived from FDCs that possess and present antigens to B cells in the follicular (germinal) centers of lymphoid organs. They often occur in lymph nodes, although they can also arise at extranodal sites. In this review, we have highlighted the morphological and immunohistochemical properties of these neoplasms, which could help in unequivocal and accurate diagnosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24369219     DOI: 10.3960/jslrt.53.179

Source DB:  PubMed          Journal:  J Clin Exp Hematop        ISSN: 1346-4280


  9 in total

1.  Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.

Authors:  Fabio Facchetti; Stefano Aldo Pileri; Luisa Lorenzi; Valentina Tabanelli; Lisa Rimsza; Stefania Pittaluga; Stephan Dirnhofer; Christiane Copie-Bergman; Laurence de Leval; Andreas Rosenwald; Andrew Wotherspoon; Falko Fend
Journal:  Virchows Arch       Date:  2017-07-10       Impact factor: 4.064

Review 2.  Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma: report of a case and review of literature.

Authors:  Zheng Su; Gaojie Liu; Jianping Liu; Tingfeng Fang; Yunjie Zeng; Huayao Zhang; Shanglin Yang; Yang Wang; Junmin Zhang; Jinxing Wei; Yingru Li; Youfeng Guo
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Spontaneous regression of interdigitating dendritic sarcoma in a patient with concurrent small lymphocytic lymphoma.

Authors:  Tamer Khashab; Lalit Sehgal; L Jeffrey Medeiros; Felipe Samaniego
Journal:  BMJ Case Rep       Date:  2015-06-12

4.  Characteristics, management, and outcomes of patients with follicular dendritic cell sarcoma.

Authors:  Preetesh Jain; Sarah A Milgrom; Keyur P Patel; Loretta Nastoupil; Luis Fayad; Michael Wang; Chelsea C Pinnix; Bouthaina S Dabaja; Grace L Smith; Jun Yu; Shimin Hu; Carlos E Bueso Ramos; Rashmi Kanagal-Shamanna; L Jeffrey Medeiros; Yasuhiro Oki; Nathan Fowler
Journal:  Br J Haematol       Date:  2017-04-06       Impact factor: 6.998

Review 5.  Interdigitating dendritic cell sarcoma: analysis of two original extra-nodal cases and review of literature.

Authors:  Jiayu Zhou; Qingling Li; Xiaodan Fu; Deyun Feng; Keda Yang; Junpu Wang
Journal:  Virchows Arch       Date:  2022-04-09       Impact factor: 4.064

6.  High fever as an initial symptom of primary gastric inflammatory myofibroblastic tumor in an adult woman.

Authors:  Jiang-Feng Qiu; Yi-Jiu Shi; Lei Fang; Hui-Fang Wang; Mou-Cheng Zhang
Journal:  Int J Clin Exp Med       Date:  2014-05-15

7.  Follicular dendritic cell sarcoma with atypical features surrounding undescended testis: description of a rare case.

Authors:  Alberto Testori; Stefano Meroni; Piergiuseppe Colombo; Stefano Fiori; Emanuele Voulaz; Marco Alloisio
Journal:  World J Surg Oncol       Date:  2015-02-21       Impact factor: 2.754

Review 8.  Diffuse lesion and necrosis tied to poorer prognosis of interdigitating dendritic cell sarcoma: cases report and a pooled analysis.

Authors:  Feng Shi; Qingkun Song; Lingling Wang; Ying Gao; Hong Chang
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

9.  U-DCS: characterization of the first permanent human dendritic sarcoma cell line.

Authors:  Kevin Mellert; Julian Benckendorff; Frank Leithäuser; Katarzyna Zimmermann; Peter Wiegand; Giada Frascaroli; Michaela Buck; Muriel Malaise; Gunther Hartmann; Winfried Barchet; Daniel Fürst; Joannis Mytilineos; Regine Mayer-Steinacker; Andreas Viardot; Peter Möller
Journal:  Sci Rep       Date:  2020-12-04       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.